The short answer
Both were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and both use a Pro-Gly-Pro extension for stability, but their bioactive fragments come from unrelated parent peptides: Semax from ACTH, Selank from tuftsin, an immunomodulatory fragment of immunoglobulin G.
Key facts
- Semax parent
- ACTH (adrenocorticotropic hormone)
- Selank parent
- Tuftsin (IgG-derived tetrapeptide)
- Shared design feature
- Pro-Gly-Pro extension
- Common origin
- Institute of Molecular Genetics, RAS
- Semax PubMed records
- ~231
- Selank PubMed records
- ~135
- Western approval
- Neither
The same design philosophy, different starting material
Both peptides follow one strategy: take a short bioactive fragment of a larger endogenous peptide, append Pro-Gly-Pro to make it durable. What differs is the fragment. Semax starts from ACTH, a pituitary hormone. Selank starts from tuftsin, a tetrapeptide derived from the Fc region of immunoglobulin G with described immunomodulatory activity. Those parents have nothing to do with one another.
Why the shared motif does not make them similar
It is easy to read 'both use Pro-Gly-Pro' as implying a family relationship. It does not. The extension is a stabilisation device, not the source of activity; the design assumption in both cases is that the pharmacophore sits in the retained fragment. Two peptides sharing a stabilising tail are no more related than two proteins sharing a purification tag.
Research material referenced
Semax 10mg, third-party HPLC tested
Different research literatures
Semax's literature centres on neurotrophin expression, neuroprotection in ischaemia models and cognition, with roughly 231 indexed records. Selank's centres on anxiolytic and immunomodulatory activity, consistent with its tuftsin origin, with roughly 135. Both share the pattern of internationally published preclinical work alongside clinical literature concentrated in Russian-language journals.
What tuftsin is
Tuftsin is a tetrapeptide, Thr-Lys-Pro-Arg, released from the heavy chain of immunoglobulin G. It was described as stimulating phagocytic activity in macrophages and neutrophils, which is why Selank's reported activity profile leans immunomodulatory in a way Semax's does not.
Shared regulatory position
Neither holds a marketing authorisation from the MHRA, EMA or FDA. Both have Russian registration histories. Both are supplied here for laboratory research only, and the same distinction applies to each: a registration elsewhere is a fact about another regulator's decision, not a therapeutic claim we make.
Quick reference
| Semax | Selank | |
|---|---|---|
| Parent peptide | ACTH | Tuftsin (IgG-derived) |
| Bioactive fragment | ACTH(4-7) | Tuftsin |
| Stabilising motif | Pro-Gly-Pro | Pro-Gly-Pro |
| Research emphasis | Neurotrophins, ischaemia | Anxiolytic, immunomodulatory |
| PubMed records | ~231 | ~135 |
| Western approval | None | None |
Frequently asked questions
Are Semax and Selank the same class of peptide?
They share a design approach and a stabilising motif, but their bioactive fragments come from unrelated parent peptides: ACTH and tuftsin.
Does the Pro-Gly-Pro make them act similarly?
No. It is a stabilisation device rather than the source of activity; the pharmacophore in each sits in the retained fragment.
Is either approved in the West?
Neither. Both hold Russian registration histories and no MHRA, EMA or FDA authorisation.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More Semax (ACTH Fragment Peptide) articles
- Where ACTH, Alpha-MSH and Beta-Endorphin All Come FromProopiomelanocortin is cleaved into different products in different tissues. The peptides it yields underlie three separate product categories here.
- Semax, MT-2 and KPV Are Pieces of the Same SequenceSemax keeps alpha-MSH residues 4-7. MT-2's core is residues 6-9. KPV is 11-13. Three product categories carved from one 13-residue hormone.
- Where This Line of Research StartedBefore Semax existed, ACTH(4-10) itself was studied for effects on memory and attention. Two 1970s papers set the question that Semax inherited.
- What the Melanocortin Neuroprotection Literature ReportsCatania 2008 reviewed neuroprotective actions of melanocortins. Giuliani 2006 examined MC4R-stimulating melanocortins in cerebral ischaemia models.
- A Mechanism Layer Below Gene ExpressionKolbaev 2025 examined Semax and calcium dynamics in rat brain neurons - a faster timescale than the neurotrophin expression work.